Insider Transactions in Q1 2025 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
George K Ng Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
87,200
+50.0%
|
$0
$0.8 P/Share
|
|
Jan 27
2025
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Indirect |
43,500
+50.0%
|
$0
$0.8 P/Share
|
|
Jan 27
2025
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
124,500
+37.74%
|
$0
$0.8 P/Share
|